Pharmacotherapy in COVID-19; A narrative review for emergency providers
N Mehta, M Mazer-Amirshahi, N Alkindi… - The American journal of …, 2020 - Elsevier
Introduction The COVID-19 pandemic has been particularly challenging due to a lack of
established therapies and treatment guidelines. With the rapid transmission of disease, even …
established therapies and treatment guidelines. With the rapid transmission of disease, even …
Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project)
Background COVID-19 is a rapidly spreading virus infection that has quickly caused
extensive burden to individual, families, countries, and the globe. No intervention has yet …
extensive burden to individual, families, countries, and the globe. No intervention has yet …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
[HTML][HTML] Recent advances in management of COVID-19: A review
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
significant mortality and economic consequences all over the globe. As of today, there are …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Current understanding of COVID-19 clinical course and investigational treatments
RB Aguilar, P Hardigan, B Mayi, D Sider… - Frontiers in …, 2020 - frontiersin.org
Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …
established viral levels, clinical tests, inflammatory markers, and investigational treatment …
Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …
quickly spread globally. Several treatments have been proposed, many of which have …
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Background Numerous clinical trials and observational studies have investigated various
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …
Ongoing clinical trials for the management of the COVID-19 pandemic
MP Lythgoe, P Middleton - Trends in pharmacological sciences, 2020 - cell.com
COVID-19 has rapidly developed into a worldwide pandemic with a significant health and
economic burden. There are currently no approved treatments or preventative therapeutic …
economic burden. There are currently no approved treatments or preventative therapeutic …
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19
A global outbreak of the SARS-CoV-2 virus has infected millions of people over a short
period of time. The communicability and increased mortality from the SARS-CoV-2 infection …
period of time. The communicability and increased mortality from the SARS-CoV-2 infection …